{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:26:10Z","timestamp":1783052770820,"version":"3.54.6"},"reference-count":27,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T00:00:00Z","timestamp":1350345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oral lichen planus (OLP) is a common disease of the oral mucosa with worldwide distribution and overall prevalence of 0.5\u20132.2%. Its etiology remains unclear, although the role of autoimmunity is supported by its association with other autoimmune diseases and the presence of auto\u2010cytotoxic T\u2003cell clones in the lesions. Although many options for treating symptomatic OLP are available, no therapy is curative. This trial compared treatments with topical tacrolimus 0.1% ointment and topical clobetasol propionate 0.05% ointment. Forty patients with histologically proven symptomatic OLP were divided into two groups of 20 to receive clobetasol propionate (0.05%) ointment or tacrolimus (0.1%) ointment for eight weeks. Follow\u2010up for all patients included three visits during the treatment course and one post\u2010treatment visit. At each visit, objective improvement in the lesions was assessed by two independent investigators. The primary outcome measure was defined as the percentage of patients attaining complete response at eight\u2003weeks. Secondary outcome measures were the percentages of patients attaining complete or partial response at 8 and 12\u2003weeks. Patient\u2010observed improvement was evaluated at each visit. Demographic parameters and pretreatment disease characteristics were comparable between the groups. The mean net clinical score (NCS) declined progressively from baseline at each follow\u2010up visit in both groups. In the clobetasol group, the mean NCS declined from 8.00\u2003\u00b1\u20032.65 at baseline to 2.00\u2003\u00b1\u20031.49 at 12\u2003weeks. In the tacrolimus group, the mean NCS declined from 7.78\u2003\u00b1\u20033.25 at baseline to 1.31\u2003\u00b1\u20031.06 at 12\u2003weeks. At each visit, the decline in mean NCS from baseline was statistically significant (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05) in both groups. Complete response rates of 40% and 70%, respectively, were achieved in the clobetasol and tacrolimus groups (<jats:italic>P\u2003<\/jats:italic>=\u20030.057). The percentages of patients reporting \u201cgood\u201d or \u201cvery good\u201d treatment responses at week\u20038 were 74% in the clobetasol group and 100% in the tacrolimus group (<jats:italic>P\u2003<\/jats:italic>&gt;\u20030.05). No severe adverse events were reported. Tacrolimus 0.1% ointment is an effective alternative to topical steroid and may be considered as a first\u2010line therapy in OLP.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2012.05459.x","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T09:39:41Z","timestamp":1350380381000},"page":"1371-1378","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double\u2010blind trial"],"prefix":"10.1111","volume":"51","author":[{"given":"Sidharth","family":"Sonthalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(85)90210-5"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2340\/0001555552216220","article-title":"Prevalence of oral lichen planus among 7639 Indian villagers in Kerala, South India","volume":"52","author":"Pindborg JJ","year":"1972","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2340\/0001555559255257","article-title":"Incidence rate of oral lichen planus among Indian villagers","volume":"5","author":"Bhonsle RB","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.06.077"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/154411130201300405"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(99)70033-8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.06.076"},{"key":"e_1_2_6_9_2","first-page":"466","article-title":"Longterm efficacy and safety of topical tacrolimus in the management of ulcerative\/erosive oral lichen planus","volume":"1325","author":"Hodgson T","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120535"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410018247"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2006.02.033"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.12.1508"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126275"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119648"},{"key":"e_1_2_6_16_2","first-page":"419","article-title":"Successful treatment of erosive lichen planus with topical tacrolimus","volume":"137","author":"Lener EV","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02672.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.10.1335"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.07.013"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2009.00830.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0070"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2007.07.029"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2007.01191.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.5.574"},{"key":"e_1_2_6_25_2","first-page":"331","article-title":"Potential future dermatological indications for tacrolimus ointment","volume":"13","author":"Ruzicka T","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2001.301006.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(94)90318-2"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.01.054"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2012.05459.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2012.05459.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:38:44Z","timestamp":1697348324000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2012.05459.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1111\/j.1365-4632.2012.05459.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05459.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,16]]},"assertion":[{"value":"2012-10-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}